Literature DB >> 12531547

Ceramide and cell death receptor clustering.

Erich Gulbins1, Heike Grassmé.   

Abstract

Acid sphingomyelinase (ASM) has been shown to be activated by a variety of receptor molecules and stimuli including CD95, the tumor necrosis factor receptor (TNF-R), CD40, CD28, LFA-1, CD5, during development, irradiation, heat shock, UV light or bacterial and viral infections. The central role of ASM-released ceramide in the response to those stimuli is confirmed by several genetic studies. ASM and ceramide might mediate their biological effects by the activation of several intracellular signaling molecules including cathepsin D, phospholipase A(2) or the kinase suppressor of Ras. In addition, recent fluorescence microscopy studies indicate that distinct, small membrane domains, termed rafts, are modified by ceramide to form larger domains, which serve to cluster receptor molecules. The generation of a high receptor density might be required for initiation of receptor-specific signaling and explain the function of the ASM and ceramide in multiple signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531547     DOI: 10.1016/s1388-1981(02)00334-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis.

Authors:  Michal Levy; S Sianna Castillo; Tzipora Goldkorn
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

2.  Native ligands change integrin sequestering but not oligomerization in raft-mimicking lipid mixtures.

Authors:  Amanda P Siegel; Ann Kimble-Hill; Sumit Garg; Rainer Jordan; Christoph A Naumann
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

3.  Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis.

Authors:  Glady Hazitha Samuel; Stefania Lenna; Andreea M Bujor; Robert Lafyatis; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2012-06-26       Impact factor: 4.563

4.  One-pot system for synthesis, assembly, and display of functional single-span membrane proteins on oil-water interfaces.

Authors:  Peter J Yunker; Haruichi Asahara; Kuo-Chan Hung; Corey Landry; Laura R Arriaga; Ilke Akartuna; John Heyman; Shaorong Chong; David A Weitz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

5.  Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.

Authors:  Nicholas J Harmer; Christopher J Robinson; Lucy E Adam; Leopold L Ilag; Carol V Robinson; John T Gallagher; Tom L Blundell
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

Review 6.  Death receptor signals to mitochondria.

Authors:  Roya Khosravi-Far; Mauro Degli Esposti
Journal:  Cancer Biol Ther       Date:  2004-11-18       Impact factor: 4.742

Review 7.  Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Authors:  Lara Milane; Shanthi Ganesh; Shruti Shah; Zhen-Feng Duan; Mansoor Amiji
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

Review 8.  Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms.

Authors:  Si Jin; Fan Zhou
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

9.  Bilayer asymmetry influences integrin sequestering in raft-mimicking lipid mixtures.

Authors:  Noor F Hussain; Amanda P Siegel; Yifan Ge; Rainer Jordan; Christoph A Naumann
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

10.  High-sensitivity analysis of glycosphingolipids by matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight imaging mass spectrometry on transfer membranes.

Authors:  Naoko Goto-Inoue; Takahiro Hayasaka; Yuki Sugiura; Takao Taki; Yu-Teh Li; Mineo Matsumoto; Mitsutoshi Setou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-06-06       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.